Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125575241 | 12557524 | 1 | I | 20160624 | 20160705 | 20160714 | 20160714 | EXP | US-BAYER-2016-132679 | BAYER | 55.00 | YR | A | M | Y | 0.00000 | 20160714 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125575241 | 12557524 | 1 | PS | NEXAVAR | SORAFENIB | 1 | 200 MG, BID | BXH9XU1 | 21923 | 200 | MG | FILM-COATED TABLET | BID | ||||||
| 125575241 | 12557524 | 2 | C | WARFARIN | WARFARIN | 1 | 0 | ||||||||||||
| 125575241 | 12557524 | 3 | C | NADOLOL. | NADOLOL | 1 | 0 | ||||||||||||
| 125575241 | 12557524 | 4 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 125575241 | 12557524 | 5 | C | BUPRENORPHINE. | BUPRENORPHINE | 1 | 0 | ||||||||||||
| 125575241 | 12557524 | 6 | C | MAXZIDE | HYDROCHLOROTHIAZIDETRIAMTERENE | 1 | 0 | ||||||||||||
| 125575241 | 12557524 | 7 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 125575241 | 12557524 | 8 | C | KLOR-CON | POTASSIUM CHLORIDE | 1 | 0 | ||||||||||||
| 125575241 | 12557524 | 9 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 125575241 | 12557524 | 10 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | 0 | ||||||||||||
| 125575241 | 12557524 | 11 | C | OXYCODONE | OXYCODONE | 1 | 0 | ||||||||||||
| 125575241 | 12557524 | 12 | C | VITAMIN A | VITAMIN A | 1 | 0 | ||||||||||||
| 125575241 | 12557524 | 13 | C | CENTRUM SILVER | MINERALSVITAMINS | 1 | 0 | ||||||||||||
| 125575241 | 12557524 | 14 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 125575241 | 12557524 | 15 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | 0 | ||||||||||||
| 125575241 | 12557524 | 16 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125575241 | 12557524 | 1 | Hepatocellular carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125575241 | 12557524 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125575241 | 12557524 | Accidental overdose | |
| 125575241 | 12557524 | Altered state of consciousness | |
| 125575241 | 12557524 | Ammonia increased | |
| 125575241 | 12557524 | Hepatic encephalopathy | |
| 125575241 | 12557524 | Lethargy | |
| 125575241 | 12557524 | Palmar-plantar erythrodysaesthesia syndrome | |
| 125575241 | 12557524 | Physical product label issue | |
| 125575241 | 12557524 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125575241 | 12557524 | 1 | 20160624 | 20160705 | 0 |